|

Effects of Exercise Training in Survivors of Lymphoma

RECRUITINGN/ASponsored by Norwegian School of Sport Sciences
Actively Recruiting
PhaseN/A
SponsorNorwegian School of Sport Sciences
Started2024-03-20
Est. completion2028-09-01
Eligibility
Age20 Years – 70 Years
Healthy vol.Accepted

Summary

This study aims to compare the effects of aerobic exercise with or without addition of resistance exercise to usual care in individuals treated with anthracyclines for lymphomas and to compare exercise effects to age- and sex-matched individuals with no prior history of malignant diseases.

Eligibility

Age: 20 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria Lymphoma participants:

* Listed in relevant registers
* Confirmed lymphoma diagnosis (i.e., Hodgkin lymphoma and aggressive non-Hodgkin lymphoma)
* Completed treatment in the past two to five years without relapse or second cancer
* Previous anthracycline treatment with or without mediastinal radiation
* No severe cancer-related fatigue (per self-report)

Inclusion Criteria Lymphoma participants and non-cancer reference group:

* Currently not performing \>75 minutes/week of aerobic exercise
* Willing and able to adhere to all study procedures.

Exclusion Criteria Lymphoma participants:

* Relapse since diagnosis
* A history, or current presence, of another diagnosis of invasive cancer of any kind

Exclusion Criteria Lymphoma participants and non-cancer reference group:

* Presence of any uncontrolled- or recent cardiovascular disease
* Has undergone heart surgery
* Uses a pacemaker
* Pregnancy
* Unable to read and understand Swedish (applicable for the Swedish site only)
* Unable to read and understand Norwegian (applicable for the Norwegian site)
* Any physical or mental health condition restricting adherence to study protocol

Conditions7

CancerCardiotoxicityCardiovascular DiseasesChemotherapeutic ToxicityHeart DiseaseLymphomaPhysical Exercise

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.